The Commission on Synthetic Opioids Report published February 8, 2022
The Commission on Combating Synthetic Opioid Trafficking, established under Section 7221 of the National Defense Authorization Act for Fiscal Year 2020, was charged with examining aspects of the synthetic opioid threat to the United States—specifically, with developing a consensus on a strategic approach to combating the illegal flow of synthetic opioids into the United States. The Commission was composed of representatives of seven executive branch departments and agencies, four sitting members of both the Senate and the House of Representatives, and four subject-matter experts from the private sector chosen for their deep experience and expertise on this topic.
The Commission Report identified five pillars with specific action items:
-Develop a unified, central body to coordinate planning, implementation, and evaluation of all U.S. drug policies;
-Disrupt drug supply through targeted oversight and enforcement;
-Make public health demand-reduction approaches central in the fight against opioid trafficking to reduce the number of potential buyers;
-Collaborate with other countries involved in the production and distribution of synthetic opioids and their chemical precursors;
-Improve surveillance and data analysis to allow for more timely and effective interventions.
How much progress has been made in implementing these recommendations by the current administration and where is that being reported and tracked ?
https://lnkd.in/dpXFYbWt